These U.S. and Canadian companies are scheduled to report their quarterly earnings today. Below is a preview of their key earning metrics, based on consensus estimates of analysts polled by Bloomberg. We have also provided analysts’ consensus buy ratings for these stocks with upside/downside potential for the upcoming 12-months.
| Company | Ticker | Exchange | Market Cap (MM) |
Last Price | Industry | Reporting Time |
Quarter | Sales ($MM) (Growth) |
Net Income ($MM) (Growth) |
EPS ($) (Growth) |
Total Analyst Coverage |
Buy Ratings | Upside Potential |
| Orbite Aluminae Inc | ORT | TSX | 84.4 | 0.37 | Metal-Aluminum | BMO | 4Q 2013 | NA | -2.70 (54.9%) |
-0.01 (75.0%) |
2 | 50% | 305.4% |
| Alphatec Holdings Inc | ATEC | NASDAQ | 135.6 | 1.39 | Medical Products | AMC | 4Q 2013 | 52.50 (-0.5%) |
-2.65 (50.6%) |
-0.03 (50.0%) |
7 | 57% | 125.9% |
| KiOR Inc | KIOR | NASDAQ | 126.6 | 1.15 | Energy-Alternate Sources | NA | 4Q 2013 | 1.09 (1154.0%) |
-43.05 (-45.0%) |
-0.38 (-33.9%) |
7 | 43% | 95.7% |
| Acorn Energy Inc | ACFN | NASDAQ | 74.9 | 3.38 | Computer Services | AMC | 4Q 2013 | 6.04 (25.7%) |
-5.02 (7.3%) |
-0.23 (25.0%) |
2 | 100% | 77.5% |
| Harvest Natural Resources Inc | HNR | NYSE | 175.4 | 4.34 | Oil Comp-Explor&Prodtn | BMO | 4Q 2013 | NA | -22.00 (5.0%) |
-0.54 (8.5%) |
3 | 67% | 61.3% |
| Health Insurance Innovations Inc | HIIQ | NASDAQ | 155.4 | 11.21 | Life/Health Insurance | NA | 4Q 2013 | 15.67 (NA) |
0.31 (NA) |
0.05 (NA) |
4 | 100% | 49.4% |
| LMI Aerospace Inc | LMIA | NASDAQ | 192.6 | 14.98 | Aerospace/Defense-Equip | BMO | 4Q 2013 | 104.67 (45.5%) |
0.20 (-79.0%) |
0.03 (-68.8%) |
5 | 40% | 46.9% |
| Tsakos Energy Navigation Ltd | TNP | NYSE | 504.3 | 7.01 | Transport-Marine | BMO | 4Q 2013 | 97.58 (44.5%) |
-9.18 (62.4%) |
-0.11 (75.6%) |
10 | 80% | 36.6% |
| Fibrocell Science Inc | FCSC | NYSE | 247.0 | 6.20 | Medical-Biomedical/Gene | NA | 4Q 2013 | 0.05 (NA) |
NA | -0.32 (NA) |
4 | 75% | 35.8% |
| JA Solar Holdings Co Ltd | JASO | NASDAQ | 494.0 | 11.42 | Energy-Alternate Sources | BMO | 4Q 2013 | 1786.06 (6.9%) |
-68.57 (89.3%) |
-1.38 (58.3%) |
8 | 50% | 35.7% |
| Sterling Construction Co Inc | STRL | NASDAQ | 165.8 | 9.95 | Building-Heavy Construct | BMO | 4Q 2013 | 153.00 (-3.2%) |
-23.70 (-910.0%) |
-0.99 (NM) |
5 | 40% | 30.7% |
| Inovio Pharmaceuticals Inc | INO | NYSE | 793.1 | 3.50 | Medical-Biomedical/Gene | BMO | 4Q 2013 | 1.89 (66.8%) |
-7.37 (-1018.8%) |
-0.04 (NA) |
6 | 67% | 28.6% |
| Global Power Equipment Group Inc | GLPW | NASDAQ | 330.2 | 19.39 | Machinery-Therml Process | AMC | 4Q 2013 | 135.60 (-10.9%) |
5.57 (-61.4%) |
0.33 (-61.8%) |
8 | 75% | 26.4% |
| DIRTT Environmental Solutions | DRT | TSX | 220.4 | 3.20 | Diversified Manufact Op | BMO | 4Q 2013 | 35.05 (NA) |
-1.90 (NA) |
-0.04 (NA) |
3 | 100% | 22.4% |
| Chesswood Group Ltd | CHW | TSX | 165.2 | 16.56 | Finance-Leasing Compan | NA | 4Q 2013 | 25.85 (NA) |
NA | 0.24 (-24.2%) |
2 | 100% | 16.2% |
| Churchill Corp | CUQ | TSX | 236.6 | 9.51 | Building&Construct-Misc | BMO | 4Q 2013 | 288.33 (-0.5%) |
NA | 0.08 (-96.9%) |
10 | 50% | 15.1% |
| Ensign Energy Services Inc | ESI | TSX | 2,585.5 | 16.86 | Oil&Gas Drilling | BMO | 4Q 2013 | 552.17 (4.2%) |
41.93 (-13.5%) |
0.29 (-10.6%) |
14 | 29% | 12.8% |
| Navigator Holdings Ltd | NVGS | NYSE | 1,381.0 | 24.96 | Transport-Marine | AMC | 3Q 2014 | 69.30 (17.1%) |
21.57 (NA) |
0.39 (62.5%) |
8 | 88% | 11.2% |
| Ares Commercial Real Estate Corp | ACRE | NYSE | 379.6 | 13.33 | REITS-Mortgage | NA | 4Q 2013 | 13.60 (178.6%) |
2.80 (112.9%) |
0.07 (-50.0%) |
7 | 86% | 10.7% |
| KYTHERA Biopharmaceuticals Inc | KYTH | NASDAQ | 1,007.4 | 46.43 | Medical-Biomedical/Gene | AMC | 4Q 2013 | NA | -14.63 (18.9%) |
-0.70 (33.1%) |
7 | 71% | 1.2% |
| Pernix Therapeutics Holdings | PTX | NASDAQ | 129.7 | 3.49 | Medical-Drugs | BMO | 4Q 2013 | 21.70 (19.3%) |
NA | -0.09 (-80.0%) |
5 | 20% | 0.3% |
| Parkervision Inc | PRKR | NASDAQ | 499.2 | 5.37 | Networking Products | AMC | 4Q 2013 | 0.13 (NA) |
-6.66 (-7.9%) |
-0.07 (0.0%) |
1 | 100% | NA |
| TrovaGene Inc | TROV | NASDAQ | 110.0 | 5.82 | Medical-Biomedical/Gene | NA | 4Q 2013 | 0.15 (-9.8%) |
-4.47 (29.5%) |
-0.23 (46.5%) |
2 | 100% | NA |
Source: Bloomberg
Note: Sales, Net Income & EPS are Bloomberg estimated figures and the growth rates mentioned are year-over-year.
BMO: Before Market Open
AMC: After Market Close
NA: Not Available
NM: Not Meaningful
